Paul Turner, Ph.D.
He/Him
Yale University
Paul Turner, Ph.D., is the Rachel Carson Professor of Ecology and Evolutionary Biology (EEB) at Yale University, and microbiology faculty member at Yale School of Medicine. He obtained a B.A. in biology (1988) from the University of Rochester in New York, a Ph.D. in microbial evolution (1995) from Michigan State University and did postdocs at National Institutes of Health, University of Valencia in Spain and University of Maryland-College Park, before joining Yale in 2001.
Turner previously served as Director of Graduate Studies and Chair of the Yale EEB department and as Interim Dean of Science at Yale. He currently serves as Director of the Center for Phage Biology and Therapy at Yale and also directs Yale’s Quantitative Biology Institute.
Turner studies evolutionary genetics of viruses, particularly phages (bacteria-specific viruses) that infect bacterial pathogens and RNA viruses transmitted by mosquitoes, and researches the use of phages to treat antibiotic-resistant bacterial diseases. He is very active in science communication outreach to the general public and is involved in the Yale National Initiative where faculty collaborate with K-12 teachers to improve STEMM education in underserved public schools.
Turner’s current service includes the National Science Foundation’s Bio Advisory Committee and the Health and Medicine Division of the National Academies of Science, Engineering and Medicine. He also serves as President of the International Society for Evolution, Medicine and Public Health. Turner’s honors include fellowships in the National Academy of Sciences, American Academy of Arts & Sciences and American Academy of °®¶¹´«Ã½.
Turner previously served as Director of Graduate Studies and Chair of the Yale EEB department and as Interim Dean of Science at Yale. He currently serves as Director of the Center for Phage Biology and Therapy at Yale and also directs Yale’s Quantitative Biology Institute.
Turner studies evolutionary genetics of viruses, particularly phages (bacteria-specific viruses) that infect bacterial pathogens and RNA viruses transmitted by mosquitoes, and researches the use of phages to treat antibiotic-resistant bacterial diseases. He is very active in science communication outreach to the general public and is involved in the Yale National Initiative where faculty collaborate with K-12 teachers to improve STEMM education in underserved public schools.
Turner’s current service includes the National Science Foundation’s Bio Advisory Committee and the Health and Medicine Division of the National Academies of Science, Engineering and Medicine. He also serves as President of the International Society for Evolution, Medicine and Public Health. Turner’s honors include fellowships in the National Academy of Sciences, American Academy of Arts & Sciences and American Academy of °®¶¹´«Ã½.